If you are at #EPILifestyle24 make sure to catch Michael D. Green’s talk. His leadership on this important work has been incredible and the talk/poster will be well worth the visit!

Incredible paper from Ziad Obermeyer et al. that provides further support to argument made by Utibe R. Essien, MD MPH Stacie Dusetzina and I in JAMA Health Forum jamanetwork.com/journals/jama-…. Cost-sharing for chronic disease treatments is likely killing patients and undermining health equity: reform needed!

Honored to receive the Appleseed teaching award— many of my favorite residents as a Duke med student were prior award recipients. One of the highlights of my intern year has been getting to engage with incredible Duke University School of Medicine medical students!

The number of persons who would need to be treated over 3 years to prevent one primary-outcome event was 20, with significant reduction in both renal and CV outcomes #T2D #CVD #CKD nejm.org/doi/full/10.10…

Many suggest we overuse statins based on INSPIRES. Can someone explain to me how a positive secondary endpoint (functional status) and neutral safety endpoint supports this? I cannot see it. Plus everyone in this trial got statins eventually regardless. jamanetwork.com/journals/jaman…